Viewing StudyNCT00439556



Ignite Creation Date: 2024-05-05 @ 5:21 PM
Last Modification Date: 2024-10-26 @ 9:31 AM
Study NCT ID: NCT00439556
Status: COMPLETED
Last Update Posted: 2019-09-10
First Post: 2007-02-22

Brief Title: Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell Transplant
Sponsor: MD Anderson Cancer Center
Organization: MD Anderson Cancer Center

Organization Data

Organization: MD Anderson Cancer Center
Class: OTHER
Study ID: 2006-0066
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: MD Anderson Cancer Center
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH